Does OSELTAMIVIR Cause Mobility decreased? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Mobility decreased have been filed in association with OSELTAMIVIR (oseltamavir phosphate). This represents 0.1% of all adverse event reports for OSELTAMIVIR.
7
Reports of Mobility decreased with OSELTAMIVIR
0.1%
of all OSELTAMIVIR reports
0
Deaths
3
Hospitalizations
How Dangerous Is Mobility decreased From OSELTAMIVIR?
Of the 7 reports, 3 (42.9%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSELTAMIVIR. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does OSELTAMIVIR Cause?
Vomiting (1,561)
Off label use (1,538)
Nausea (1,055)
No adverse event (810)
Drug ineffective (688)
Dyspnoea (582)
Diarrhoea (553)
Hallucination (502)
Influenza (443)
Rash (439)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which OSELTAMIVIR Alternatives Have Lower Mobility decreased Risk?
OSELTAMIVIR vs OSILODROSTAT
OSELTAMIVIR vs OSIMERTINIB
OSELTAMIVIR vs OSPEMIFENE
OSELTAMIVIR vs OSPHENA
OSELTAMIVIR vs OVINE DIGOXIN IMMUNE FAB